Held on 02 May 2017
The Board of Directors of Omkar Speciality Chemicals at its meeting held on 02 May 2017 transacted the following -Adopted the order of Composite Scheme of Arrangement approved by NCLT on 13 April 2017.
To make an investment of Rs 2.23 crore by subscribing to 22,36,445 equity shares of Rs 10 each in Lasa Supergenerics in accordance with the Scheme of Arrangement.
Take on record, upon demerger, transfer of fixed assets and liabilities of the Company to Lasa Supergenerics.
Accepted the resignation of directors with effect from 02 May 2017 - Omkar Herlekar, Subhash Mali, Subhash Ghalke, Dr Suhas Rane and Vikas Gadre.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
